These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Standardization of laboratory tests for tuberculosis and their proficiency testing]. Abe C Kekkaku; 2003 Aug; 78(8):541-51. PubMed ID: 14509226 [TBL] [Abstract][Full Text] [Related]
4. [Identification of Mycobacterium tuberculosis strains and a simultaneous identification of their drug resistance by the hybridization method on oligonucleotide microchips]. Griadunov DA; Mikhaĭlovich VM; Lapa SA; Rudinskiĭ NI; Barskiĭ VE; Chudinov AV; Zasedatelev AS; Mirzabekov AD Mol Gen Mikrobiol Virusol; 2003; (4):24-7. PubMed ID: 14664159 [TBL] [Abstract][Full Text] [Related]
5. Molecular characterization of isoniazid resistance in Mycobacterium tuberculosis: identification of a novel mutation in inhA. Leung ET; Ho PL; Yuen KY; Woo WL; Lam TH; Kao RY; Seto WH; Yam WC Antimicrob Agents Chemother; 2006 Mar; 50(3):1075-8. PubMed ID: 16495272 [TBL] [Abstract][Full Text] [Related]
6. Molecular detection, identification and drug resistance detection in Mycobacterium tuberculosis. Palomino JC FEMS Immunol Med Microbiol; 2009 Jul; 56(2):103-11. PubMed ID: 19416361 [TBL] [Abstract][Full Text] [Related]
7. Detection of multidrug resistance in Mycobacterium tuberculosis. Sekiguchi J; Miyoshi-Akiyama T; Augustynowicz-Kopeć E; Zwolska Z; Kirikae F; Toyota E; Kobayashi I; Morita K; Kudo K; Kato S; Kuratsuji T; Mori T; Kirikae T J Clin Microbiol; 2007 Jan; 45(1):179-92. PubMed ID: 17108078 [TBL] [Abstract][Full Text] [Related]
8. A simple method to differentiate between Mycobacterium tuberculosis and non-tuberculous mycobacteria directly on clinical specimens. Varma-Basil M; Kumar S; Yadav J; Kumar N; Bose M Southeast Asian J Trop Med Public Health; 2007 Jan; 38(1):111-4. PubMed ID: 17539255 [TBL] [Abstract][Full Text] [Related]
9. Relation between catalase activity, virulence and drug resistance of some strains of Mycobacterium tuberculosis isolated from pathological human specimens. FISSI-MARRACCINI G; GUERRA M Boll Ist Sieroter Milan; 1959; 38(3-4):106-13. PubMed ID: 13651411 [No Abstract] [Full Text] [Related]
10. Isoniazid's bactericidal activity ceases because of the emergence of resistance, not depletion of Mycobacterium tuberculosis in the log phase of growth. Gumbo T; Louie A; Liu W; Ambrose PG; Bhavnani SM; Brown D; Drusano GL J Infect Dis; 2007 Jan; 195(2):194-201. PubMed ID: 17191164 [TBL] [Abstract][Full Text] [Related]
11. [The external quality assessment for Mycobacterium tuberculosis drug susceptibility testing by proficiency testing panel to the commercial laboratories]. Mitarai S; Kekkaku; 2005 Apr; 80(4):349-58. PubMed ID: 15991600 [TBL] [Abstract][Full Text] [Related]
12. Development and evaluation of a line probe assay for rapid identification of pncA mutations in pyrazinamide-resistant mycobacterium tuberculosis strains. Sekiguchi J; Nakamura T; Miyoshi-Akiyama T; Kirikae F; Kobayashi I; Augustynowicz-Kopec E; Zwolska Z; Morita K; Suetake T; Yoshida H; Kato S; Mori T; Kirikae T J Clin Microbiol; 2007 Sep; 45(9):2802-7. PubMed ID: 17596354 [TBL] [Abstract][Full Text] [Related]
13. Correlation between isoniazid resistance and superoxide reactivity in mycobacterium tuberculosis KatG. Ghiladi RA; Medzihradszky KF; Rusnak FM; Ortiz de Montellano PR J Am Chem Soc; 2005 Sep; 127(38):13428-42. PubMed ID: 16173777 [TBL] [Abstract][Full Text] [Related]
14. Rapid genotypic assays to identify drug-resistant Mycobacterium tuberculosis in South Africa. Evans J; Stead MC; Nicol MP; Segal H J Antimicrob Chemother; 2009 Jan; 63(1):11-6. PubMed ID: 18940875 [TBL] [Abstract][Full Text] [Related]
15. Is second-line anti-tuberculosis drug susceptibility testing reliable? Kim SJ; Espinal MA; Abe C; Bai GH; Boulahbal F; Fattorin L; Gilpin C; Hoffner S; Kam KM; Martin-Casabona N; Rigouts L; Vincent V Int J Tuberc Lung Dis; 2004 Sep; 8(9):1157-8. PubMed ID: 15455606 [No Abstract] [Full Text] [Related]
16. katG mutations in isoniazid-resistant strains of Mycobacterium tuberculosis isolates from Belarusian patients. Zaker Bostanabad S; Titov LP; Slizen VV; Taghikhani M; Bahrmand A Tuberk Toraks; 2007; 55(3):231-7. PubMed ID: 17978919 [TBL] [Abstract][Full Text] [Related]
17. Rapid mycobacteria drug susceptibility testing using Gel Microdrop (GMD) Growth Assay and flow cytometry. Akselband Y; Cabral C; Shapiro DS; McGrath P J Microbiol Methods; 2005 Aug; 62(2):181-97. PubMed ID: 16009276 [TBL] [Abstract][Full Text] [Related]
18. New rifabutin analogs: synthesis and biological activity against Mycobacterium tuberculosis. Barluenga J; Aznar F; García AB; Cabal MP; Palacios JJ; Menéndez MA Bioorg Med Chem Lett; 2006 Nov; 16(22):5717-22. PubMed ID: 16987658 [TBL] [Abstract][Full Text] [Related]
19. Drug susceptibility testing of Mycobacterium tuberculosis complex by use of a high-throughput, reproducible, absolute concentration method. van Klingeren B; Dessens-Kroon M; van der Laan T; Kremer K; van Soolingen D J Clin Microbiol; 2007 Aug; 45(8):2662-8. PubMed ID: 17537932 [TBL] [Abstract][Full Text] [Related]
20. Extensively drug-resistant Mycobacterium tuberculosis during a trend of decreasing drug resistance from 2000 through 2006 at a Medical Center in Taiwan. Lai CC; Tan CK; Huang YT; Chou CH; Hung CC; Yang PC; Luh KT; Hsueh PR Clin Infect Dis; 2008 Oct; 47(7):e57-63. PubMed ID: 18715157 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]